TARDBP and neuroblastoma: To explore the link between GSK3 activity and TDP-43 fragmentation, SH-SY5Y neuroblastoma cells expressing TDP-43N-Del, TDP-43WT or TDP-43Q331K were treated with the GSK3 inhibitors CHIR99021 and AZD1080 (Fig. 4a).